113 related articles for article (PubMed ID: 22410648)
1. White matter hyperintensities predict amyloid increase in Alzheimer's disease.
Grimmer T; Faust M; Auer F; Alexopoulos P; Förstl H; Henriksen G; Perneczky R; Sorg C; Yousefi BH; Drzezga A; Kurz A
Neurobiol Aging; 2012 Dec; 33(12):2766-73. PubMed ID: 22410648
[TBL] [Abstract][Full Text] [Related]
2. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
3. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
[TBL] [Abstract][Full Text] [Related]
4. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia.
Gordon BA; Najmi S; Hsu P; Roe CM; Morris JC; Benzinger TL
Neuroimage Clin; 2015; 8():246-52. PubMed ID: 26106548
[TBL] [Abstract][Full Text] [Related]
5. Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?
Brickman AM; Muraskin J; Zimmerman ME
Dialogues Clin Neurosci; 2009; 11(2):181-90. PubMed ID: 19585953
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E-e4, processing speed, and white matter volume in a genetically enriched sample of midlife adults.
Ready RE; Baran B; Chaudhry M; Schatz K; Gordon J; Spencer RM
Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):463-8. PubMed ID: 21937476
[TBL] [Abstract][Full Text] [Related]
7. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
Zhang J; Chen H; Wang J; Huang Q; Xu X; Wang W; Xu W; Guan Y; Liu J; Wardlaw JM; Deng Y; Xie F; Li B
Alzheimers Dement; 2024 Apr; ():. PubMed ID: 38648354
[TBL] [Abstract][Full Text] [Related]
8. Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
Brickman AM
Curr Neurol Neurosci Rep; 2013 Dec; 13(12):415. PubMed ID: 24190781
[TBL] [Abstract][Full Text] [Related]
9. Sex-dependent alterations in hippocampal connectivity are linked to cerebrovascular and amyloid pathologies in normal aging.
Schweitzer N; Li J; Thurston RC; Lopresti B; Klunk WE; Snitz B; Tudorascu D; Cohen A; Kamboh MI; Halligan-Eddy E; Iordanova B; Villemagne VL; Aizenstein H; Wu M
Alzheimers Dement; 2024 Feb; 20(2):914-924. PubMed ID: 37817668
[TBL] [Abstract][Full Text] [Related]
10. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
[TBL] [Abstract][Full Text] [Related]
11. Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline.
Wang R; Fratiglioni L; Laukka EJ; Lövdén M; Kalpouzos G; Keller L; Graff C; Salami A; Bäckman L; Qiu C
Neurology; 2015 Mar; 84(11):1128-35. PubMed ID: 25672924
[TBL] [Abstract][Full Text] [Related]
12. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.
Birdsill AC; Koscik RL; Jonaitis EM; Johnson SC; Okonkwo OC; Hermann BP; Larue A; Sager MA; Bendlin BB
Neurobiol Aging; 2014 Apr; 35(4):769-76. PubMed ID: 24199958
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.
Noh Y; Seo SW; Jeon S; Lee JM; Kim JH; Kim GH; Cho H; Yoon CW; Kim HJ; Ye BS; Kim ST; Choe YS; Lee KH; Kim JS; Ewers M; Weiner MW; Lee JH; Werring DJ; Kang DR; Kim CS; Na DL
J Alzheimers Dis; 2014; 40(4):877-86. PubMed ID: 24577457
[TBL] [Abstract][Full Text] [Related]
14. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.
Wardlaw JM; Smith EE; Biessels GJ; Cordonnier C; Fazekas F; Frayne R; Lindley RI; O'Brien JT; Barkhof F; Benavente OR; Black SE; Brayne C; Breteler M; Chabriat H; Decarli C; de Leeuw FE; Doubal F; Duering M; Fox NC; Greenberg S; Hachinski V; Kilimann I; Mok V; Oostenbrugge Rv; Pantoni L; Speck O; Stephan BC; Teipel S; Viswanathan A; Werring D; Chen C; Smith C; van Buchem M; Norrving B; Gorelick PB; Dichgans M;
Lancet Neurol; 2013 Aug; 12(8):822-38. PubMed ID: 23867200
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
[TBL] [Abstract][Full Text] [Related]
16. Associations between amyloid β and white matter hyperintensities: A systematic review.
Roseborough A; Ramirez J; Black SE; Edwards JD
Alzheimers Dement; 2017 Oct; 13(10):1154-1167. PubMed ID: 28322203
[TBL] [Abstract][Full Text] [Related]
17. Association between retinal microvascular abnormalities and late-life brain amyloid-β deposition: the ARIC-PET study.
Egle M; Deal JA; Walker KA; Wong DF; Sharrett AR; Gottesman RF
Alzheimers Res Ther; 2024 May; 16(1):100. PubMed ID: 38711107
[TBL] [Abstract][Full Text] [Related]
18. Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer's Disease.
Carroll CM; Benca RM
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540695
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular disease drives Alzheimer plasma biomarker concentrations in adults with Down syndrome.
Edwards NC; Lao PJ; Alshikho MJ; Ericsson OM; Rizvi B; Petersen ME; O'Bryant S; Flores-Aguilar L; Simoes S; Mapstone M; Tudorascu DL; Janelidze S; Hansson O; Handen BL; Christian BT; Lee JH; Lai F; Rosas HD; Zaman S; Lott IT; Yassa MA; Gutierrez J; Wilcock DM; Head E; Brickman AM
medRxiv; 2023 Nov; ():. PubMed ID: 38076904
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
